SARS-CoV-2-specific T cells and antibodies in COVID-19 protection: a prospective study
During the ongoing coronavirus disease COVID-19 pandemic, many individuals were infected with and have cleared the virus, developing virus-specific antibodies and effector/memory T cells. An important unanswered question is what levels of T cell and antibody responses are sufficient to protect from the infection.

Список научных проектов, где отмечена публикация
- DZM-30-3. . Внебюджетное финансирование.
- 075-15-2020-899. . Внебюджетное финансирование.
- KNP-06/21. . Внебюджетное финансирование.